Literature DB >> 25789845

Cell Therapy for Stress Urinary Incontinence.

Melanie L Hart1, Ander Izeta2, Bernardo Herrera-Imbroda3, Bastian Amend4, Jan E Brinchmann5,6.   

Abstract

Urinary incontinence (UI) is the involuntary loss of urine and is a common condition in middle-aged and elderly women and men. Stress urinary incontinence (SUI) is caused by leakage of urine when coughing, sneezing, laughing, lifting, and exercise, even standing leads to increased intra-abdominal pressure. Other types of UI also exist such as urge incontinence (also called overactive bladder), which is a strong and unexpected sudden urge to urinate, mixed forms of UI that result in symptoms of both urge and stress incontinence, and functional incontinence caused by reduced mobility, cognitive impairment, or neuromuscular limitations that impair mobility or dexterity. However, for many SUI patients, there is significant loss of urethral sphincter muscle due to degeneration of tissue, the strain and trauma of pregnancy and childbirth, or injury acquired during surgery. Hence, for individuals with SUI, a cell-based therapeutic approach to regenerate the sphincter muscle offers the advantage of treating the cause rather than the symptoms. We discuss current clinically relevant cell therapy approaches for regeneration of the external urethral sphincter (striated muscle), internal urethral sphincter (smooth muscle), the neuromuscular synapse, and blood supply. The use of mesenchymal stromal/stem cells is a major step in the right direction, but they may not be enough for regeneration of all components of the urethral sphincter. Inclusion of other cell types or biomaterials may also be necessary to enhance integration and survival of the transplanted cells.

Entities:  

Mesh:

Year:  2015        PMID: 25789845     DOI: 10.1089/ten.TEB.2014.0627

Source DB:  PubMed          Journal:  Tissue Eng Part B Rev        ISSN: 1937-3368            Impact factor:   6.389


  12 in total

1.  Smooth Muscle Precursor Cells Derived from Human Pluripotent Stem Cells for Treatment of Stress Urinary Incontinence.

Authors:  Zhe Wang; Yan Wen; Yan Hui Li; Yi Wei; Morgaine Green; Prachi Wani; Pengbo Zhang; Renee Reijo Pera; Bertha Chen
Journal:  Stem Cells Dev       Date:  2016-03-15       Impact factor: 3.272

2.  A cocktail of growth factors released from a heparin hyaluronic-acid hydrogel promotes the myogenic potential of human urine-derived stem cells in vivo.

Authors:  Guihua Liu; Rongpei Wu; Bin Yang; Yingai Shi; Chunhua Deng; Anthony Atala; Steven Mou; Tracy Criswell; Yuanyuan Zhang
Journal:  Acta Biomater       Date:  2020-02-08       Impact factor: 8.947

3.  Stromal derived factor-1 plasmid as a novel injection for treatment of stress urinary incontinence in a rat model.

Authors:  Ahmad O Khalifa; Michael Kavran; Amr Mahran; Ilaha Isali; Juliana Woda; Chris A Flask; Marc S Penn; Adonis K Hijaz
Journal:  Int Urogynecol J       Date:  2019-01-21       Impact factor: 2.894

4.  Local versus intravenous injections of skeletal muscle precursor cells in nonhuman primates with acute or chronic intrinsic urinary sphincter deficiency.

Authors:  J Koudy Williams; Gopal Badlani; Ashley Dean; Shannon Lankford; Kimberly Poppante; Tracy Criswell; Karl-Erik Andersson
Journal:  Stem Cell Res Ther       Date:  2016-10-07       Impact factor: 6.832

5.  Evaluation of Urinary Sphincter Function by Rapid Magnetic Resonance Diffusion Tensor Imaging.

Authors:  Florian A Schmid; Ryszard S Gomolka; Andreas M Hötker; Andreas Boss; Thomas M Kessler; Cristina Rossi; Daniel Eberli
Journal:  Int Neurourol J       Date:  2020-12-31       Impact factor: 2.835

Review 6.  Terminal Schwann Cell Aging: Implications for Age-Associated Neuromuscular Dysfunction.

Authors:  Sandra Fuertes-Alvarez; Ander Izeta
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

7.  Smooth Muscle-Like Cells Generated from Human Mesenchymal Stromal Cells Display Marker Gene Expression and Electrophysiological Competence Comparable to Bladder Smooth Muscle Cells.

Authors:  Juliane Brun; Katrin A Lutz; Katharina M H Neumayer; Gerd Klein; Tanja Seeger; Tatiana Uynuk-Ool; Katharina Wörgötter; Sandra Schmid; Udo Kraushaar; Elke Guenther; Bernd Rolauffs; Wilhelm K Aicher; Melanie L Hart
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

Review 8.  Cell Therapy Clinical Trials for Stress Urinary Incontinence: Current Status and Perspectives.

Authors:  Isabel María Aragón; Bernardo Herrera Imbroda; María Fernanda Lara
Journal:  Int J Med Sci       Date:  2018-01-01       Impact factor: 3.738

9.  Lack of a skeletal muscle phenotype in adult human bone marrow stromal cells following xenogeneic-free expansion.

Authors:  Dominik Barisic; Marita Erb; Marie Follo; Dahlia Al-Mudaris; Bernd Rolauffs; Melanie L Hart
Journal:  Stem Cell Res Ther       Date:  2020-02-22       Impact factor: 6.832

10.  Feasibility, technique and accuracy of ultrasound-guided transurethral injections into the urinary sphincter of female cadavers: proof of concept.

Authors:  Florian A Schmid; Dominic Gascho; Niklaus Zoelch; Jenny A Prange; Giovanni Colacicco; Daniel Eberli
Journal:  BMC Urol       Date:  2020-10-23       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.